Hollingsworth DR, Mabry CCCongenital Graves disease. Am J Dis Child.1976;130:148-155.
2.
Dallas JS, Foley TP Jr. Hyperthyroidism. In: Lifshitz F , ed. Pediatric Endocrinology. New York, NYMarcel Dekker; 1990:483-500.
3.
Jacobson BB, Andersen HS, Peitersen B., et al. Serum levels of thyrotropin, and T3 in full term, SGA, and pre-term newborn babies. Acta Paediatrica Scand.1977 ;66:681-687.
4.
Wilson DM, Hopper AO, McDougall IR, et al. Serum free values in term, premature, and sick infants. J Pediatr.1982;101:113-117.
5.
Wu SY, Chopra IJ, Solomon DH, Ben-nett LRChanges in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate. J Clin Endocrinol Metab.1978 ;46:691-697.
6.
Caldwell G., Errington M., Toft ADResistant hyperthyroidism induced by sodium ipodate used as treatment for Graves' disease. Acta Endocrinol (Copenh). 1989;120:215-216.
7.
Wu SY, Shyh TP, Chopra IJ, et al. Comparison of sodium ipodate and PTU in early treatment of hyperthyroidism . J Clin Endocrinol Metab.1982;54:630-634.
8.
Roti E., Robuschi G., Gardini E., et al. Comparison of methimazole, methimazole and sodium ipodate, and methimazole and SSKI in the early treatment of Graves' disease. Clin Endocrinology. 1988;28:305-314.
9.
Karpman BA, Rapaport B., Filetti S., Fisher DATreatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate . J Clin Endocrinol Metab.1987;64:119-123.
10.
Daneman D., Howard NJNeonatal thyrotoxicosis: intellectual impairment and craniosynostosis in late years. J Pediatr.1980;97:257-259.